Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Li, Chuan ^a   Wen, Tian Fu ^a   Yan, Lu Nan ^a   Li, Bo ^a   Yang, Jia Ying ^a   Xu, Ming Qing ^a   Wang, Wen Tao ^a   Wei, Yong Gang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE MARKER; FEMALE; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; SURVIVAL RATE; TISSUE DONORS;

EID: 84882693222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072235     Document Type: Article

References (36)

1. Llovet JM, Bruix J, (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48Suppl 1: S20-37.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699.
4. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403.
5. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864-871.
6. Toso C, Trotter J, Wei A, Bigam DL, Shah S, et al. (2008) Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 14: 1107-1115.
7. Dumitra TC, Dumitra S, Metrakos PP, Barkun JS, Chaudhury P, et al. (2013) Pretransplantation alpha-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation 95: 228-233.
8. Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, et al. (2012) Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 143: 986-994 e983; quiz e914-985.
9. Nemes B, Gelley F, Piros L, Zadori G, Gorog D, et al. (2011) The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Transplant Proc 43: 1272-1274.
10. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10: 35-43.
11. Halazun KJ, Hardy MA, Rana AA, Woodland DC III, Luyten EJ, et al. (2009) Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma. Ann Surg 250: 141-151.
12. Chen T-M, Lin C-C, Huang P-T, Wen C-F, (2012) Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. J Gastroenterol Hepatol 27: 553-561.
13. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, et al. (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32: 1757-1762.
14. Zhang L, Wang JN, Tang JM, Kong X, Yang JY, et al. (2012) VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep 39: 5085-5093.
15. Wang R, Zhao N, Li S, Fang JH, Chen MX, et al. (2013) MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42. Hepatology.
16. Wu Y, Liu C, Sun M, Shen H, Guo D, et al. (2010) A specific cytotoxic T-lymphocyte epitope presentation system for antitumor immunity. Int J Cancer 126: 2373-2386.
17. Wang H-T, Lee H-I, Guo J-H, Chen S-H, Liao Z-K, et al. (2012) Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules. Int J Cancer 130: 2892-2902.
18. Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, et al. (2013) Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 58: 58-64.
19. Western CE, Aroori S, Bowles M, Stell D, (2012) Preoperative neutrophil:lympocyte ratio does not predict posto-operative complications following hepatic resection. Gut 61: A192.
20. Eto M, Kamiryo Y, Takeuchi A, Harano M, Tatsugami K, et al. (2008) Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor. Clin Cancer Res 14: 2833-2840.
21. Lo CM, Fan ST, Liu CL, Chan SC, Ng IOL, et al. (2007) Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94: 78-86.
22. Fisher RA, Kulik LM, Freise CE, Lok ASF, Shearon TH, et al. (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7: 1601-1608.
23. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, et al. (2009) Living Donor Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Compared With Deceased Donor Liver Transplantation. Transplant Proc 41: 1283-1285.
24. Man K, Fan ST, Lo CM, Liu CL, Fung PCW, et al. (2003) Graft injury in relation to graft size in right lobe live donor liver transplantation- A study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 237: 256-264.
25. Man K, Lo CM, Lee TKW, Li XL, Ng IOL, et al. (2003) Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl 9: 425-432.
26. Jiang S-M, Zhou G-W, Zhang R, Peng C-H, Yan J-Q, et al. (2009) Role of Splanchnic Hemodynamics in Liver Regeneration After Living Donor Liver Transplantation. Liver Transpl 15: 1043-1049.
27. Liang W, Wu L, Ling X, Schroder PM, Ju W, et al. (2012) Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: A meta-analysis. Liver Transpl 18: 1226-1236.
28. Grant RC, Sandhu L, Dixon PR, Greig PD, Grant DR, et al. (2013) Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant 27: 140-147.
29. Lee HH, Joh J, Park JH, Lee KW, Heo JS, et al. (2005) Microvascular tumor embolism: Independent prognostic factor after liver transplantation in hepatocellular carcinoma. Transplant Proc 37: 1251-1253.
30. Moon JI, Kwon CHD, Joh JW, Choi GS, Jung GO, et al. (2012) Primary Versus Salvage Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: Impact of Microvascular Invasion on Survival. Transplant Proc 44: 487-493.
31. Shah SA, Tan JCC, McGilvray ID, Cattral MS, Levy GA, et al. (2007) Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 11: 464-471.
32. Ataide EC, Boin IFSF, Almeida JRS, Seva-Pereira T, Stucchi RSB, et al. (2011) Prognostic Factors for Hepatocellular Carcinoma Recurrence: Experience With 83 Liver Transplantation Patients. Transplant Proc 43: 1362-1364.
33. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, et al. (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15: 1375-1382.
34. Roayaie S, Blume IN, Thung SN, Guido M, Fiel M-I, et al. (2009) A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma. Gastroenterology 137: 850-855.
35. Wittnich C, Belanger MP, Askin N, Boscarino C, Wallen WJ, (2004) Lower liver transplant success in females: Gender differences in metabolic response to global ischemia. Transplant Proc 36: 1485-1488.
36. Burra P, De Martin E, Gitto S, Villa E, (2013) Influence of Age and Gender Before and After Liver Transplantation. Liver Transpl 19: 122-134.